Cogent Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COGT and other ETFs, options, and stocks.About COGT
Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17.
CEOAndrew R. Robbins
CEOAndrew R. Robbins
Employees205
Employees205
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2014
Founded2014
Employees205
Employees205
COGT Key Statistics
Market cap5.86B
Market cap5.86B
Price-Earnings ratio-16.26
Price-Earnings ratio-16.26
Dividend yield—
Dividend yield—
Average volume5.00M
Average volume5.00M
High today$38.87
High today$38.87
Low today$36.71
Low today$36.71
Open price$36.79
Open price$36.79
Volume3.84M
Volume3.84M
52 Week high$38.87
52 Week high$38.87
52 Week low$3.72
52 Week low$3.72
Stock Snapshot
The current Cogent Biosciences(COGT) stock price is $38.50, with a market capitalization of 5.86B. The stock trades at a price-to-earnings (P/E) ratio of -16.26.
On 2025-11-25, Cogent Biosciences(COGT) stock traded between a low of $36.71 and a high of $38.87. Shares are currently priced at $38.50, which is +4.9% above the low and -1.0% below the high.
Cogent Biosciences(COGT) shares are trading with a volume of 3.84M, against a daily average of 5M.
During the past year, Cogent Biosciences(COGT) stock moved between $3.72 at its lowest and $38.87 at its peak.
During the past year, Cogent Biosciences(COGT) stock moved between $3.72 at its lowest and $38.87 at its peak.
Analyst ratings
83%
of 12 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own COGT. This list is generated using Robinhood data, and it’s not a recommendation.